Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00347594 · ClinicalTrials.gov registry record · NA
A Clinical Evaluation of the Next Generation Diagnostic Instrument (NGDI)
A NA study of Healthy, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 76
- Enrollment target
- 1
- Study location
NCT00347594: Completed NA study of Healthy, sponsored by Bausch & Lomb Incorporated.
NCT00347594 is a NA study of Healthy that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 76 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00347594, a NA study of Healthy, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 76 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to measure the aberrations, corneal surface topography and pachymetry of normal human eyes with the NGDI.
Conditions Studied
Interventions
- DEVICE Next Generation Diagnostic Instrument (NGDI)
- DEVICE Zyoptix Diagnostic Workstation (ZDW)
Study Locations (1)
New York
- Bausch & Lomb - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2005-08 |
| Est. Completion | 2006-09 |
| Phase | NA |
What the finished NCT00347594 record still lists
NCT00347594 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 76 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Next Generation Diagnostic Instrument (NGDI) is the first listed.
NCT00347594 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00347594 about?
NCT00347594 is a clinical study titled "A Clinical Evaluation of the Next Generation Diagnostic Instrument (NGDI)". The purpose of this study is to measure the aberrations, corneal surface topography and pachymetry of normal human eyes with the NGDI.
What is the current status of trial NCT00347594?
This trial is currently completed. It is a NA study. The enrollment target is 76 participants. The study started on 2005-08. Estimated completion is 2006-09.
What conditions does trial NCT00347594 study?
This clinical trial studies the following conditions: Healthy.
What interventions are being tested in trial NCT00347594?
The interventions under investigation include: Next Generation Diagnostic Instrument (NGDI) (DEVICE), Zyoptix Diagnostic Workstation (ZDW) (DEVICE).
Who is sponsoring clinical trial NCT00347594?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00347594 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00347594's enrollment target sits among peer trials
76 295th of 1090 higher than 792 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study
RECRUITING · NA
-
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
RECRUITING · NA
-
Medical Illustration Design Characteristic Evaluation
RECRUITING · NA
-
Sodium vs Potassium Education to Improve Vascular Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02615184 · 76 participants · Phase 2
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
- NCT02821741 · 76 participants · NA
Effects of External Ear Stimulation on Pain Perception and Mood
- NCT03019757 · 76 participants
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- NCT03353584 · 76 participants · NA
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia